These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 27988384)

  • 1. The opposing roles of NO and oxidative stress in cardiovascular disease.
    Ritchie RH; Drummond GR; Sobey CG; De Silva TM; Kemp-Harper BK
    Pharmacol Res; 2017 Feb; 116():57-69. PubMed ID: 27988384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular Therapeutic Potential of the Redox Siblings, Nitric Oxide (NO•) and Nitroxyl (HNO), in the Setting of Reactive Oxygen Species Dysregulation.
    Kemp-Harper BK; Velagic A; Paolocci N; Horowitz JD; Ritchie RH
    Handb Exp Pharmacol; 2021; 264():311-337. PubMed ID: 32813078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NADPH oxidases, reactive oxygen species, and hypertension: clinical implications and therapeutic possibilities.
    Paravicini TM; Touyz RM
    Diabetes Care; 2008 Feb; 31 Suppl 2():S170-80. PubMed ID: 18227481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppressing NADPH oxidase-dependent oxidative stress in the vasculature with nitric oxide donors.
    Selemidis S
    Clin Exp Pharmacol Physiol; 2008 Nov; 35(11):1395-401. PubMed ID: 18954334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of exercise training on redox signaling in cardiovascular diseases.
    Campos JC; Gomes KM; Ferreira JC
    Food Chem Toxicol; 2013 Dec; 62():107-19. PubMed ID: 23978413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidative stress in patients with cardiovascular disease and chronic renal failure.
    Popolo A; Autore G; Pinto A; Marzocco S
    Free Radic Res; 2013 May; 47(5):346-56. PubMed ID: 23438723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular redox dysfunction in the development of cardiovascular diseases.
    Kanaan GN; Harper ME
    Biochim Biophys Acta Gen Subj; 2017 Nov; 1861(11 Pt A):2822-2829. PubMed ID: 28778485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular NADPH oxidases as drug targets for novel antioxidant strategies.
    Guzik TJ; Harrison DG
    Drug Discov Today; 2006 Jun; 11(11-12):524-33. PubMed ID: 16713904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxidative stress and diabetic cardiovascular disorders: roles of mitochondria and NADPH oxidase.
    Shen GX
    Can J Physiol Pharmacol; 2010 Mar; 88(3):241-8. PubMed ID: 20393589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NADPH oxidase-derived reactive oxygen species: involvement in vascular physiology and pathology.
    Manea A
    Cell Tissue Res; 2010 Dec; 342(3):325-39. PubMed ID: 21052718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sources of Vascular Nitric Oxide and Reactive Oxygen Species and Their Regulation.
    Tejero J; Shiva S; Gladwin MT
    Physiol Rev; 2019 Jan; 99(1):311-379. PubMed ID: 30379623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel therapeutic approaches in limiting oxidative stress and inflammation.
    Spychalowicz A; Wilk G; Śliwa T; Ludew D; Guzik TJ
    Curr Pharm Biotechnol; 2012 Oct; 13(13):2456-66. PubMed ID: 22280420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular mechanisms of hypertension--reactive oxygen species and antioxidants: a basic science update for the clinician.
    Montezano AC; Touyz RM
    Can J Cardiol; 2012 May; 28(3):288-95. PubMed ID: 22445098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nitric oxide synthase inhibition and oxidative stress in cardiovascular diseases: possible therapeutic targets?
    Rochette L; Lorin J; Zeller M; Guilland JC; Lorgis L; Cottin Y; Vergely C
    Pharmacol Ther; 2013 Dec; 140(3):239-57. PubMed ID: 23859953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Oxidative stress and vascular function].
    Urbański K; Nowak M; Guzik TJ
    Postepy Biochem; 2013; 59(4):424-31. PubMed ID: 24745173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular oxidative stress, nitric oxide and atherosclerosis.
    Li H; Horke S; Förstermann U
    Atherosclerosis; 2014 Nov; 237(1):208-19. PubMed ID: 25244505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelial function and oxidative stress in cardiovascular diseases.
    Higashi Y; Noma K; Yoshizumi M; Kihara Y
    Circ J; 2009 Mar; 73(3):411-8. PubMed ID: 19194043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nitroxyl (HNO): the Cinderella of the nitric oxide story.
    Irvine JC; Ritchie RH; Favaloro JL; Andrews KL; Widdop RE; Kemp-Harper BK
    Trends Pharmacol Sci; 2008 Dec; 29(12):601-8. PubMed ID: 18835046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of apocynin on vascular disease in hypertension.
    Virdis A; Gesi M; Taddei S
    Vascul Pharmacol; 2016 Dec; 87():1-5. PubMed ID: 27569106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nitroxide antioxidant as a potential strategy to attenuate the oxidative/nitrosative stress induced by hydrogen peroxide plus nitric oxide in cultured neurons.
    Lee CT; Yu LE; Wang JY
    Nitric Oxide; 2016 Apr; 54():38-50. PubMed ID: 26891889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.